Abstract
The human preterm brain is particularly susceptible to cerebral white matter injury (WMI) that disrupts the normal progression of developmental myelination. Advances in the care of preterm infants have resulted in a sustained reduction in the severity of WMI that has shifted from more severe focal necrotic lesions to milder diffuse WMI. Nevertheless, WMI remains a global health problem and the most common cause of chronic neurological morbidity from cerebral palsy and diverse neurobehavioral disabilities. Diffuse WMI involves maturation-dependent vulnerability of the oligodendrocyte (OL) lineage with selective degeneration of late oligodendrocyte progenitors (preOLs) triggered by oxidative stress and other insults. The magnitude and distribution of diffuse WMI are related to both the timing of appearance and regional distribution of susceptible preOLs. Diffuse WMI disrupts the normal progression of OL lineage maturation and myelination through aberrant mechanisms of regeneration and repair. PreOL degeneration is accompanied by early robust proliferation of OL progenitors that regenerate and augment the preOL pool available to generate myelinating OLs. However, newly generated preOLs fail to differentiate and initiate myelination along their normal developmental trajectory despite the presence of numerous intact-appearing axons. Disrupted preOL maturation is accompanied by diffuse gliosis and disturbances in the composition of the extracellular matrix and is mediated in part by inhibitory factors derived from reactive astrocytes. Signaling pathways implicated in disrupted myelination include those mediated by Notch, WNT-beta catenin, and hyaluronan. Hence, there exists a potentially broad but still poorly defined developmental window for interventions to promote white matter repair and myelination and potentially reverses the widespread disturbances in cerebral gray matter growth that accompanies WMI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Significance of preterm WMI as a global health problem
Preterm birth continues to be a major global health problem associated with considerable mortality and morbidity. The world health organization estimates that about 15 million preterm infants (1 in 10 live births) are born less than 37-week post-conceptional age world wide each year. Preterm birth is the leading cause of death of babies less than 5 years [115]. Rates of prematurity vary considerably even among countries with considerable resources and range from 5 to 18%. The rate of prematurity is markedly higher in the United States, for example, compared to many countries in Europe and reached a rate of 9.6% in 2015 [36]. In the U.S. alone each year, very low birth weight (VLBW) infants comprise about 1.5% of the 4 million live births. Hence, the world wide social and economic burden is considerable and relates in large part to the chronic sequelae associated with WMI. The average lifetime costs for each person with cerebral palsy (CP) are about 1 million dollars in the United States [1].
Although ongoing advances in the care of preterm infants have resulted in significant improvements in survival of very low birth weight (VLBW) infants (<1.5 kg), improved survival has been accompanied by a persistent increase in preterm survivors with chronic neurological disabilities [184]. Permanent motor impairment (i.e., CP) is reported in ~10% of preterm survivors and ranges from mild to profound spastic motor deficits [28, 81, 114, 129, 132, 180]. Neurodevelopment is further comprised in 25–50% of preterm survivors by a broad spectrum of cognitive, visual, social-behavioral, attention, and learning disabilities [7, 73, 96, 113, 167].
Cerebral white matter injury (WMI) is the major form of brain injury in survivors of premature birth [181]. The period of highest risk for WMI is ~23–32-week post-conceptional age. In the first months of life, MRI-defined WMI in preterm survivors manifests as abnormal movements that are predictive of CP [42, 170, 171]. The impact of WMI can be appreciated from one large population-based study of children with CP. Perinatal WMI, including the necrotic lesions of periventricular leukomalacia (PVL), was the most common finding, seen in almost half (42.5%) of affected children [27]. Moreover, premature birth alone is associated with a greater risk for reduction in both cerebral white and gray matter volumes, which are associated with adverse cognitive development [2, 8, 48, 105, 118, 142, 157, 168].
Although largely associated with premature birth, WMI may also commonly occur in some groups of full-term infants where in utero insults appear to coincide with a susceptible period in white matter development prior to the onset of cerebral myelination [106, 108, 123, 141]. WMI may occur, for example, in association with chronic placental insufficiency [120, 150, 192]. Although WMI may occur as a peri-operative complication of surgical correction of cyanotic congenital heart disease (CHD) [72, 127], WMI in this population also commonly has its origins in antenatal factors apparently related to a prolonged period of in utero ischemia or reduced cerebral oxygenation [110, 172]. This review focuses on the pathogenesis of acquired preterm human WMI and will address its relevance to develop new strategies to prevent the cellular and molecular consequences of acute and chronic WMI.
Spectrum of focal and diffuse human white matter injury
During human cerebral development, acquired WMI is a common lesion that can vary considerably in severity. Three major forms of pathology comprise the spectrum of human WMI: focal cystic necrosis, focal microscopic necrosis, and diffuse non-necrotic lesions. The relative representation of these three types of pathology in a given patient population is related to a wide variety of clinical factors that affect the antenatal or postnatal hemodynamic stability and inflammatory status of the preterm fetus or infant. These include postnatal infections, hypoxia–ischemia, hypoxemia, hypocarbia, metabolic acidosis, and hypoglycemia [19]. During intensive care, preterm infants are also often exposed routinely to multiple painful and stressful procedures that are associated with disturbances in postnatal growth [179] and brain maturation that involve both white and gray matter structures [32, 166].
Necrotic WMI evolves to macroscopic or microscopic focal lesions
The most severe form of WMI involves large regions of cystic necrosis that typically ranges from about 1 to 6 mm in diameter. These large foci of necrosis are the hallmark of PVL, which most commonly localizes deep in the white matter adjacent to the ventricular wall [143]. However, in its most severe forms, PVL can extend into the centrum semiovale and even the subcortical white matter (Fig. 1a, b). PVL has a particular predilection for the white matter anterior to the frontal horn, the external angles of the lateral ventricles at the level of the foramen of Monro, and the lateral aspects of the trigone and occipital horns adjacent to the optic radiations. Severe white matter necrosis has decreased markedly in recent years. In several series, focal cystic lesions were detected by MRI in less than 5% of cases (Fig. 1c, d) [43, 79, 84, 93, 119, 131]. Both macroscopic and microscopic forms of white matter necrosis were found to decrease by ~tenfold in contemporary cohorts relative to retrospective cases from earlier decades [33].
Cystic necrosis is initiated as coagulation necrosis that rapidly within hours leads to death of all cellular elements (glia, axons, blood vessels, and neural progenitors) because of severe energy failure. Major features include nuclear pyknosis, cytotoxic edema with tissue vacuolation, and focal axon swellings (axonal spheroids) that disrupt axonal trafficking. The latter can be appreciated with staining for neurofilament protein [18], beta-amyloid precursor protein [33], and the fractin antibody [33, 87]. Advanced axonal necrosis may be associated with mineralization of dystrophic axons that stain for calcium or iron. Necrosis progresses to the focal infiltration and reaction of macrophages and microglia, including lipid-laden macrophages visualized with markers that include CD45, CD68, Iba1, and the ricin and tomato lectins [16, 18, 30, 33]. The process of microglial reaction coincides with an early and progressive astrocyte reaction that delineates the borders of focal necrosis. These astrocytes can be visualized with GFAP, vimentin, and the hyaluronan receptor CD44 [18, 33]. When severe necrosis progresses to tissue liquefaction and cavitation, large and sometimes bizarre-appearing astroglial somata and processes form a pronounced glial scar that is enriched in extracellular matrix molecules, notably hyaluronan, and stains palely for myelin markers, such as myelin basic protein (MBP) [17, 33]. When the cavitation is large and diffuse, it may be associated with a pronounced reduction in white matter volume, thinning of the corpus callosum and ventriculomegaly.
Although large necrotic lesions have decreased markedly, discrete small foci of microscopic necrosis (microcysts) less than 1 mm in diameter continue to occur commonly [143]. Similar to focal cystic necrosis, microcysts involve tissue destruction and are enriched in cellular debris, degenerating axons and phagocytic macrophages (Fig. 1d–f). Due to their smaller diameter, microcysts are not routinely detected on clinical MRI scans at field strengths of 3 Tesla, but can be detected experimentally in tissue blocks analyzed ex vivo at higher magnetic field strengths of 12 Tesla [151]. A study of human archival and contemporary autopsy cases found that microcysts occurred in at least 30% of cases, but comprised only ~1–5% of the total burden of WMI [33]. Hence, microscopic necrosis occurs with high incidence, but the burden is typically low. The clinical importance of these small necrotic lesions remains an inaccessible question, since microcysts are not readily visualized with clinical MRI. Hence, microcysts may be clinically silent lesions or a significant contributor to motor or cognitive disabilities, depending upon the number and distribution within functionally significant regions of white matter. The distribution of microcysts is similar to that of cystic necrosis, which suggests a similar vascular ischemic origin.
The basis for the preferential localization of necrotic WMI to deep cerebral white matter remains speculative. There are apparent vascular end and border zones in the preterm periventricular white matter that may predispose to more severe ischemia [92, 135, 138, 174]. Multiple studies in human [6, 76, 144, 146,147,148] and preterm fetal sheep [74, 152, 173] found that cerebral white matter has an intrinsically lower basal cerebral blood flow compared to gray matter regions, which suggested that the susceptibility of the preterm infant to WMI is related to a heightened propensity for ischemia. Preterm infants studied by near-infrared spectroscopy displayed disturbances in cerebral cortical flow consistent with disturbances in cerebral autoregulation and a heightened risk for ischemia-induced WMI [169, 176]. Measurements of global cortical or white matter flow in human lack, however, the regional sensitivity to quantify flow in discrete regions of deep cerebral white matter where necrosis preferentially localizes. Studies in preterm fetal sheep achieved spatially resolved quantitative measurements of fetal CBF in utero that were co-registered with histologically defined analyses of WMI. These studies found that there were no pathologically significant gradients of flow between fetal cerebral cortex and deep cerebral white matter during either ischemia or reperfusion [126, 152]. Even during moderately severe global ischemia, some regions of white matter were relatively spared, whereas other neighboring regions sustained significantly greater cell death. Moreover, histologically confirmed WMI did not localize to regions susceptible to greater ischemia. Nor did less vulnerable regions of white matter have greater blood flow during ischemia. Ischemia thus appeared to be necessary but not sufficient to generate necrotic or diffuse WMI. In preterm fetal sheep, the severity of WMI was significantly associated with the magnitude of hypotension, hypoxemia, and hypoglycemia [153]. Collectively, these findings suggest that the propensity for more severe WMI is related to a combination of vascular anatomic immaturity, disturbances in cerebrovascular autoregulation, and a variety of metabolic factors that may predispose to more severe energy failure in regions of focal white matter necrosis.
Diffuse WMI is the predominant lesion in most preterm survivors
Diffuse WMI is the most common form of injury in contemporary cohorts of preterm newborns [33]. It may exist in isolation or be associated with foci of necrosis [143]. Because of its diffuse nature and the lack of discrete borders for many large regions of the centrum semiovale, it has been difficult to estimate the boundaries of diffuse lesions. We provided an estimate by adapting stereological principles to quantify the area fraction of GFAP-labeled astrocytes and Iba1-labeled microglia within putative lesions defined independently by histopathological review of hematoxylin and eosin (H & E) stained sections [33]. Unexpectedly, when the burden of astrogliosis and microgliosis was compared within putative lesions and the peri-lesion surround, the burden of reactive glia was found to be significantly elevated within the peri-lesion areas that were predicted to be normal-appearing on the basis of review of H & E staining.
Given that quantitative morphometric approaches are required to estimate the magnitude and distribution of diffuse reactive gliosis, it is not surprising that clinical imaging modalities appear to underestimate these lesions. Cranial ultrasound is the preferred bed-side imaging technique for diagnosing necrotic WMI, but it is less reliable for detection of diffuse WMI [93, 119, 131]. MRI is the preferred method to visualize diffuse WMI. On diagnostic MRI scans, WMI is visualized as either discrete focal or more diffuse areas of MR signal abnormalities [39]. The spectrum of non-cystic WMI- or “punctate” lesions has recently been described as linear or cluster lesions with different evolutions over time [104]. There is, however, unexplained variability in the nature of lesions detected at different centers, which may reflect differences in management, clinical acuity, or modes of detection. In particular, MRI appears to underestimate early diffuse lesions. Disparities between the clinical presentation and the distribution of lesions on MRI have been widely noted. Experimental studies that co-registered MRI and histopathology data demonstrated that early WMI is particularly well visualized at high magnetic field strength (12 T) [151], which suggests that currently employed clinical MRI field strengths of 1.5–3 T may be a limiting factor to detect both diffuse WMI as well as microcysts.
As discussed below, preterm survivors frequently display diffuse abnormalities in gray and white matter maturation related to preterm birth that may be more common than pathologically defined focal WMI [39]. These diffuse maturational abnormalities may be related on MRI to enlarged subarachnoid spaces, a reduction in white matter, ventriculomegaly, and impaired gyral development [59, 164]. However, many premature newborns do not have these dramatic abnormalities, and up to 20% with adverse outcomes do not have significant qualitative abnormalities on MRI [31, 132].
Diffuse WMI involves selective vulnerability of late oligodendrocyte (OL) progenitors
In contrast to necrotic injury, diffuse WMI is defined by selective degeneration of pre-oligodendrocytes (preOLs), whereas axons are mostly spared except in necrotic foci [87, 154]. Human preOLs are the predominant population of pre-myelinating OL progenitors in preterm human cerebral white matter [16]. We found that human preOLs are particularly susceptible to degeneration in preterm white matter lesions with confirmed oxidative damage defined by the levels of F2-isoprostanes, a quantifiable marker of reactive oxygen species-mediated tissue injury. Importantly, the levels of F2-isoprostanes detected in preterm lesions were similar in magnitude to those measured in moderately severe cerebral cortical hypoxic–ischemic lesions in term infants [18]. This finding supports that preterm human WMI is accompanied by a significant oxidative damage of a magnitude consistent with hypoxia–ischemia. Experimental data in support of a role for hypoxia–ischemia in acute preOL degeneration is discussed below.
The susceptibility to preterm WMI peaks at ~23–32-week post-conceptional age. During this protracted window in human pre-myelinating white matter development, human OL lineage cells develop according to a well-established sequence of maturational events, defined by stage-specific antibodies specific for sequentially expressed OL cell-surface and myelin-specific epitopes [16, 17, 97, 98]. Human preOLs are pre-myelinating late OL progenitors that are non-migratory but mitotically active (Fig. 2a–c). They label with the O4 antibody but not the O1 antibody. They derive from a population of pre-myelinating, migratory, and mitotically active early OL progenitors that label for the NG2 proteoglycan and the platelet-derived growth factor-alpha receptor (PDGFRα). Although both these OL progenitor populations are typically subsumed under the designation “OL progenitors cells” or OPCs when studied in vitro, these two successive OL stages can be differentiated, for example, by the lack of O4 labeling of the PDGFRα-labeled OL progenitors. Moreover, the OL progenitors are highly resistant to hypoxia–ischemia, whereas preOLs are very susceptible to degeneration [14]. Pre-myelinating immature OLs (O4+O1+) (Fig. 2d) and mature myelinating OLs (Fig. 2e, f) also display greater resistance to cell death from hypoxia–ischemia or kainate toxicity in vitro [14, 156].
An extensive human and experimental literature supports that preOLs are particularly susceptible to cell death, whereas other OL lineage stages are markedly more resistant [14, 18, 159]. Immature neurons in the preterm human cerebral cortex (Fig. 3a) and subcortical gray matter are also very resistant to oxidative stress as defined by cell death markers and quantitative measurements of F4-neuroprostanes, a sensitive and stable marker of oxidative damage to neuronal membranes [18]. By contrast, the preterm cerebral white matter sustains widespread preOL death under conditions that do not trigger significant degeneration of cortical neurons (Fig. 3b, c). In response to moderately severe global cerebral ischemia, immature neurons in the cerebral cortex and caudate nucleus of preterm fetal sheep were similarly found to be strikingly resistant to cell death in contrast to preOLs [45, 125].
When preOLs undergo apparent necrosis (Fig. 3d–j), they display a progressive series of morphological changes that include focal swelling of processes (Fig. 3e), followed by fragmentation, which appear as a halo around the shrunken cell body (Fig. 3g–i). With the collapse of membrane integrity, membrane-associated markers display intracellular localization (Fig. 3d–h), as can be observed with staining with the O4 antibody [18]. A striking example of terminal preOL degeneration is also shown, for example, from a PVL case in Fig. 8A, as reported by Billiards et al. [29].
Caspase-mediated mechanisms of apoptosis (Fig. 3k–m) also may contribute to acute preOL death from oxidative stress in human WMI [18] and hypoxia–ischemia in experimental models [14, 35, 38, 139]. The magnitude of caspase activation appears to be related to the severity of the hypoxic–ischemic insult. In response to moderate perinatal hypoxia–ischemia, most preOLs in rodents degenerated acutely by apparent necrosis that did not involve caspase-3 activation [14, 159]. By contrast, in the preterm sheep fetus, preOL degeneration more commonly involved activation of caspase-3, consistent with a milder insult [152]. Similar observations were made in late-gestation sheep [35, 38]. Hence, a less severe insult may result in a combination of apoptosis and necrosis, whereas more severe insults mostly trigger necrosis [40, 85]. The relative extent of apoptotic versus necrotic preOL degeneration is typically difficult to establish due to the lack of histological markers of necrosis. Ultrastructural studies from neonatal rodents in vitro and in vivo demonstrated that oxidative stress or moderate hypoxia–ischemia caused a form of oligodendroglial degeneration that displayed mixed features of necrosis and apoptosis [12, 13].
Maturation-dependent vulnerability of the human OL lineage to oxidative stress and hypoxia–ischemia
The major period of vulnerability for human WMI coincides with a developmental window when the white matter is at increased risk for oxidative stress from hypoxia–ischemia or maternal–fetal infection [68, 82]. The high-risk period for WMI thus precedes the onset of myelination [16, 149]. As noted above, the high-risk period occurs when the white matter is populated primarily by preOLs that are the principal target for cell death in white matter lesions. The decline in risk for WMI coincides with the onset of a wave of differentiation of preOLs to immature OLs that initiate myelination [17]. PreOLs are particularly susceptible to maturation-dependent mechanisms of free radical-mediated injury, whereas earlier and later OL lineage stages are much more resistant to intrinsic and extrinsic sources of oxidative stress both in vitro and in vivo [13, 14, 25, 67, 70, 112].
A role for oxidative stress in preOL degeneration is supported by in vitro, experimental and human neuropathology studies. During fetal brain development, the cerebral white matter is already enriched in membrane lipids that are readily oxidized [86, 99, 134]. The preterm white matter may be more vulnerable to oxidative damage than at term because of a delay in expression of the antioxidant enzymes, superoxide dismutases-1 and -2, catalase, and glutathione peroxidase [25, 26, 69]. However, expression data in rat and human have not been confirmed with enzyme activity data. A fetal rabbit model of reperfusion–reoxygenation demonstrated increased superoxide generation with immediate ischemia–reperfusion that was associated with a doubling in the rate of hypertonia observed in neonatal pups delivered at term. Notably, there was a significant reduction in hypertonia in response to early delivery of a superoxide dismutase mimic or anti-oxidants [55].
Although controversy exists regarding the role of reactive nitrogen species in the pathogenesis of early WMI, human preterm white matter is especially prone to lipid peroxidation-mediated injury [18, 88]. Both the biochemical and immunohistochemical detections of protein, lipid, and DNA adducts generated by reaction oxygen and nitrogen species (e.g., protein carbonyls, 4-hydroxynonenal, and 8-oxo-deoxyguanosine) are unreliable in human preterm WMI [18]. Sensitive detection of the aldehydes formed from lipid hydroperoxides in glia is specifically achieved by quantification of F2-isoprostanes, which are stable adducts in postmortem human tissue [136]. F2-isoprostanes were significantly elevated in histopathologically confirmed cases of early WMI [18] and were similar to the levels detected in the cerebral cortex where hypoxic–ischemic encephalopathy was diagnosed. This oxidative damage was accompanied by a pronounced increase in degenerating preOLs in the periventricular white matter. F4-neuroprostanes, a specific marker of oxidative injury to neuronal elements, were not detected in white matter or cerebral cortex, consistent with the notion that neurons and axons were spared. Hence, oxidative damage selectively triggers cell death in preterm human white matter. Moreover, during the early phases of WMI, the magnitude of oxidative damage is comparable to that sustained in the cerebral cortex after severe perinatal asphyxia.
As noted above, it was shown experimentally that ischemia is necessary but not sufficient to cause WMI. Even under conditions of moderately severe ischemia, some regions of white matter may be relatively spared. Consistent with observations that preOLs are selectively vulnerable to oxidative stress, the timing of appearance [34] and spatial distribution of susceptible preOLs [152] have provided an explanation for the magnitude and distribution of acute hypoxic–ischemic WMI in several experimental models of WMI. The white matter of 2-day-old preterm-equivalent rat pups, for example, displays a much greater susceptibility to hypoxia–ischemia than in 7-day-old near-term equivalent animals [14]. A major developmental difference at these two ages is the extent of differentiation of the OL lineage. At postnatal day 2, the rat white matter contains predominantly preOLs and, thus, resembles human cerebral white matter during the high-risk period for WMI [44]. By day 5, in three different strains of rat, the white matter is, in fact, populated mainly by a more differentiated population of immature OLs, and thus resembles near-term human [46]. PreOLs are very susceptible to hypoxia–ischemia, whereas earlier and later OL lineage stages are much more resistant [14, 152, 159]. The enhanced susceptibility of preOLs in vivo is, thus, a stage-specific property that is independent of the developmental age of the animal or the location of these cells in cerebral white matter.
As the white matter matures, it displays greater developmental resistance to hypoxia–ischemia that is related to the onset of preOL differentiation. As noted above, pre-myelinating immature OLs and mature myelinating OLs display reduced susceptibility to oxidative stress and hypoxia–ischemia. Similar to reactive astrocytes, immature OLs in the white matter often display a robust reactive response to cerebral injury, which is common after hypoxia–ischemia at postnatal day 7 in the rat [14]. This response coincides with gray matter injury and secondary injury to axons in the adjacent callosal white matter. Cerebral hypoxic–ischemic injury in rodents thus differs markedly from human due to substantial necrotic neuro-axonal injury. Gray matter necrosis uncommonly occurs in association with human WMI unless the latter injury also involves necrosis [22, 47, 89, 121, 143]. In preterm fetal sheep, more selective WMI is generated by global ischemia and severe necrotic WMI is typically observed under conditions of prolonged global cerebral ischemia [152]. When selective WMI is generated, the regional distribution of WMI is closely associated with the distribution of vulnerable preOLs and other neural cell types (astrocytes, microglia, and axons) are markedly more resistant to injury.
The notion that preOLs define the susceptibility to WMI is further supported by studies that asked whether WMI would occur in fetal animals that lacked preOLs in cerebral white matter tracts. In a fetal rabbit model of placental insufficiency, reduced susceptibility of the white matter to hypoxia–ischemia at embryonic day 22 (E22) was accounted for by a paucity of preOLs. During fetal rabbit white matter development, a coordinate increase in the generation of preOLs occurs in most white matter tracts around E25. By E25, a pronounced increase in preOLs coincided with a marked increase in WMI and significant degeneration of susceptible preOLs. Taken together, these findings support that perturbations in cerebral blood flow are necessary but not sufficient for WMI. The developmental predilection for WMI is related to both the timing of appearance and regional distribution of susceptible preOLs. These findings predict that some near-term infants with delayed OL differentiation and myelination may also be more susceptible to WMI. As noted above, near term and term infants with congenital heart disease are at high risk for WMI [127]. Several clinical and MRI studies support the notion that this susceptibility relates to a delay in brain maturation [41, 51, 110, 111, 133]. Hence, the targeted death of preOLs from hypoxia to ischemia or inflammatory mediators may contribute to the pathogenesis of acute human WMI across a broad range of gestational ages and regions of white matter.
Mechanisms of myelination disturbances in chronic focal or diffuse WMI
Myelin loss in chronic focal WMI involves axon degeneration
Disturbances in OL lineage maturation and myelination are central features that distinguish chronic WMI in human preterm survivors from other forms of neonatal cerebral injury. Myelination disturbances arise from two related mechanisms (Fig. 4a, upper pathway). The first involves axonal degeneration in focal WMI. Early histopathological descriptions of myelination disturbances included many cases where focal cystic necrotic WMI (PVL) with axonal degeneration was associated with diffuse white matter astrogliosis [29, 91].
Focal necrotic lesions often contain dystrophic axons and axonal spheroids, which degenerate during the early phase of coagulative necrosis [22, 47, 89, 121]. Small premyelinated axons are particularly susceptible to glutamate-mediated excitotoxicity at sites of contact with OL processes and involve both N-methyl-d-aspartic acid (NMDA) and non-NMDA glutamate receptors [4, 66]. Axons also display maturation-dependent vulnerability to oxidative stress and hypoxia–ischemia [5]. Larger caliber axons, which are preparing to myelinate, are particularly susceptible to injury via axolemma-associated voltage-gated calcium channels, in contrast to smaller caliber unmyelinated axons, which are more resistant. More diffuse axonal dysfunction (e.g., trafficking disturbances) that does not involve overt degeneration remains speculative and difficult to study due to a lack of useful histopathological markers.
The second mechanism of myelination disturbances (Fig. 4a, lower pathway) involves preOL death in diffuse WMI, which disrupts OL lineage maturation and myelination (see below). Primary axonal injury does not appear to be a major feature of diffuse human WMI during the pre-myelinating phase of white matter development. Rather, diffuse preOL death predominates but may be accompanied by axonal degeneration in sporadic focal necrotic lesions. Focal axonal loss was found to be a minor component of WMI in both sheep and human studies, where they comprised about 5% of the total burden of WMI [33, 151]. During the chronic phase of diffuse WMI in preterm fetal sheep, no significant axonal degeneration, axonal loss, or shift in the distribution of axon calibers was observed by light [151] or quantitative electron microscopy [154] studies.
In contemporary cohorts of patients, MRI more commonly defines focal or diffuse signal abnormalities that do not involve large cystic lesions. Although these diffuse MRI abnormalities are often attributed to disruption in the cellular events that contribute to pre-myelination or myelination, these studies lack histopathological correlation and the cellular–molecular basis for the white matter signal abnormalities is unclear. For example, in subjects with these milder forms of diffuse WMI, fractional anisotropy (FA) did not increase in central white matter tracts relative to normal infants [90, 128, 130], and this was proposed to be related to abnormal pre-myelination or myelination. Findings from a preterm fetal rabbit model of global cerebral ischemia [49, 53, 54] identified that the most rapid rise in FA normally occurs prior to myelination at a time when pre-myelinating immature OLs increase in number in central white matter tracts and axons show maturational changes [56]. These experimental findings suggest that MRI-defined WMI in contemporary cohorts of patients may be related to disturbances in OL lineage maturation rather than axonal degeneration, but histopathological confirmation in human is needed.
Myelination disturbances in chronic diffuse WMI are related to aberrant preOL maturation
As discussed above, focal necrotic WMI results in myelination failure, which is likely to be permanent, because it typically involves necrotic degeneration of all cell types in the lesion. The pathogenesis of diffuse chronic WMI is distinct from the process that leads to focal necrosis and may be potentially reversible. Diffuse WMI involves two major overlapping events that disrupt the normal progression of preOL differentiation and myelination in developing white matter. The initial response to injury involves an early proliferative response to WMI characterized by a significant increase in OL progenitors in subacute lesions. This plasticity response results in expansion of the pool of OL progenitors that are available to generate new preOLs to replace those that degenerate during acute WMI. The second overlapping event occurs over days to weeks after WMI and involves a disruption in the normal differentiation of newly generated preOLs to myelinating OLs. Despite the pronounced selective degeneration of preOLs in early diffuse WMI (see above), disturbances in myelination in chronic lesions do not appear to arise from a loss of myelinating OLs. Rather, newly generated OL progenitors fail to differentiate beyond the preOL stage to mature myelinating OLs. These two key events in disrupted white matter regeneration and repair are discussed in the following sections.
OL progenitor proliferative response
In several experimental studies, the total pool of preOLs in neonatal rat white matter lesions increased several fold in subacute lesions [159, 185, 191]. This robust response is initiated rapidly. Within 24 h after hypoxia–ischemia in neonatal rats, the total preOL pool was already increased 2–3 fold and continued to increase further for several days [159]. Although preOLs are a mitotically active population of cells in vitro, this robust expansion of the preOL pool appears to be mostly driven by a large reservoir of OL progenitors that proliferate locally in white matter lesions. A potential additional site for OL progenitor proliferation is the neural stem cell rich subventricular zone (SVZ). However, consistent with prior studies [65, 188, 190], we found that local proliferation of OL progenitors in the SVZ was less robust than within the lesions [159].
Human studies similarly found that the total pool of OL lineage cells was not depleted in chronic lesions [29, 33]. Although a pronounced loss of preOLs occurs during the acute phase of WMI [18], a significant diffuse increase in preOLs was found in chronic lesions from subjects that survived for at least 2–3 weeks after birth [33]. Interestingly, in age-related cognitive decline, human vascular WMI also displays a significant increase in total OL lineage cells [15] that is similar to that reported in human preterm WMI [33]. Hence, both in the developing and aging white matter, injury may trigger an initial robust OL progenitor proliferative response. Also common to both forms of WMI is a diffuse activation of microglia and astrocytes [33, 143, 178]. This diffuse inflammatory response thus accompanies the robust proliferative response of early OL progenitors and points to a generalized activation of multiple glial cell populations in response to WMI.
PreOL dysmaturation in chronic WMI
A major consequence of the chronic glial inflammatory response in chronic WMI is a disruption of the normal progression of preOL maturation and myelination. Although a large pool of preOLs are regenerated and survive in chronic lesions, they do not follow the normal trajectory for differentiation and myelination. This disruption in myelination occurs, even though experimentally generated lesions contain numerous intact axons [154, 159]. In response to focal cerebral hypoxia–ischemia in the preterm-equivalent neonatal rat, for example, the control hemisphere displays normal myelination (Fig. 4b), whereas preOLs in white matter lesions fail to differentiate or myelinate despite the presence of numerous intact-appearing axons (Fig. 4c). Notably, in diffuse WMI in preterm fetal sheep, no significant axonal degeneration, axonal loss, or shift in the distribution of axon sizes was identified by light or quantitative electron microscopy studies [151, 152, 154]. Morphometric and ultrastructural studies provide no information about the long-term functional integrity of axons, however, which may be disrupted due to lack of trophic support from oligodendrocytes [107].
In preterm-equivalent rodents and preterm fetal sheep, chronic hypoxic–ischemic WMI was accompanied by disrupted maturation of preOLs to myelinating OLs. In diffuse WMI in preterm sheep, a near doubling in preOL density coincided with about a 50% decrease in OLs [151]. Similarly, in human diffuse WMI, a significant increase in preOLs coincided with a reduction in the total percentage of OLs [33]. Moreover, in both human and preterm fetal sheep, the accumulation of preOLs in chronic lesions was significantly associated with the magnitude of astrogliosis [33, 151]. The striking lack of myelination in gliotic lesions can also be appreciated in the neonatal rat where myelinating white matter (O4+O1+) is associated with the modest levels of GFAP-labeled astrocytes (Fig. 4d) compared to injured white matter (Fig. 4e), which displays profound reductions in myelination. This lack of myelination is related to the pronounced accumulation of preOLs (O4+O1−) that fail to differentiate to myelinating OLs (Fig. 4f, g). As discussed below, a mechanistic role for several astrocyte-derived factors has been linked to preOL dysmaturation and myelination failure.
Since preOLs are highly susceptible to oxidative stress, an important unresolved question is whether the accumulation of preOLs in chronic WMI renders these lesions persistently more susceptible to recurrent injury from hypoxia–ischemia. To determine whether preOL dysmaturation extended the developmental window for susceptibility to WMI, we analyzed the severity of the WMI in response to recurrent hypoxia–ischemia. In response to recurrent hypoxia–ischemia, preterm-equivalent rodents displayed a pronounced increase in apoptotic preOL death that may have been related to loss of trophic support from diffuse neuro-axonal degeneration [159]. However, recurrent hypoxia–ischemia in preterm fetal sheep did not trigger pronounced preOL death or neuro-axonal degeneration [83]. This suggests that when only dysmature preOLs populate a chronic lesion, they may confer protection against recurrent WMI. An important future direction would be to determine if preOL dysmaturation confers upon these cells a greater resistance to oxidative stress via an ischemic tolerance-like mechanism.
Chronic WMI: what is the potential for regeneration and repair?
The persistence of a substantial pool of dysmature preOLs in WMI suggests the potential to promote repair of chronic lesions through strategies that promote preOL differentiation. Disrupted maturation of the OL progenitor pool in chronic adult WMI has been studied in experimental models of myelination failure relevant to neonatal WMI, multiple sclerosis, and vascular dementias. These studies have resulted in the identification of intrinsic, extrinsic, and epigenetic factors that regulate the OL progenitor cell cycle, preOL differentiation, and myelination [23, 58, 62, 162, 163]. Oxidative stress activates multiple genes, which regulate OL maturation, and oxidative stress promotes global histone acetylation, which can block OL differentiation [21, 50, 71, 109, 160]. Post-transcriptional control by microRNAs regulates OL differentiation and OL progenitors that lack mature microRNAs display arrested maturation [57, 161].
Disruption of the extracellular matrix is a prominent feature of chronic WMI in both the developing and aging white matter and is linked to diffuse reactive astrogliosis [15, 33, 37]. In diffuse preterm human WMI, the extracellular matrix is a particularly rich source of hyaluronic acid and one of its receptors, CD44 [33]. CD44-positive reactive astrocytes are significantly associated with the magnitude of WMI. Reactive astrocytes synthesize megadalton forms of hyaluronic acid which are associated with lesions [9]. In preterm fetal sheep, hyaluronic acid was robustly elevated in the first week after acute WMI from hypoxia–ischemia and was still modestly elevated in chronic WMI at 2 weeks [83]. A block in preOL maturation is stimulated both in vitro and in vivo by hyaluronic acid and is related to hyaluronic acid digestion products generated by CNS enriched hyaluronidases that orient to the extracellular matrix [11, 83, 145, 165]. Pharmacological inhibition of hyaluronidases promotes preOL maturation in vitro and myelination in vivo, which is accompanied by enhanced nerve conduction [145]. Reactive astrocytes also display enhanced expression of bone morphogenetic proteins that inhibit OL progenitor differentiation and promote astrocyte differentiation [183]. Reactive astrocytes display enhanced expression of the Notch ligand Jagged1 which is elevated in demyelinating lesions and activates Notch signaling in OL progenitors to prevent their maturation [101].
Dysregulation of WNT-beta catenin signaling also disrupts OL progenitor maturation, delays normal myelination, and disrupts remyelination [60, 61, 64, 124, 175, 189]. Constitutive expression of the epidermal growth factor receptor (EGFR) in neonatal white matter promotes proliferation of OL progenitors [94], and enhanced EGFR signaling stimulates adult CNS myelination and remyelination [3]. EGFR activation via an intranasally administered form of EGF reduced OL death from chronic neonatal hypoxia, promoted OL maturation and myelination, and led to functional improvement [158].
Since multiple signaling pathways are implicated in the pathogenesis of myelination failure, one therapeutic strategy has targeted multiple signaling pathways via the pleiotropic growth factor, erythropoietin (EPO), which promote angiogenesis, neurogenesis, and gliogenesis during normal brain maturation [75, 95, 100, 102, 103, 116, 187]. A randomized trial of high-dose recombinant EPO to preterm infants in the first 2 days of life was safe and associated with enhanced MRI-defined white matter maturation [63, 140], but 2 year neurodevelopmental outcomes were not improved [137]. A recent double-blinded, placebo-controlled trial of EPO administered with therapeutic hypothermia showed potential benefit for neonatal encephalopathy in term infants. MRI-defined brain injury in the perinatal period was significantly reduced and improved motor function was observed at 1 year of age [186]. Other agents that may provide at least partial protection against preterm WMI include melatonin [77], thyroxine [182], and magnesium sulfate [52]. Another potentially promising approach to block multiple cell death pathways is to combine cerebral hypothermia with an agent that protects against preOL death. In pre-clinical studies, cerebral hypothermia rendered greater global protection against WMI and preOL degeneration [24]. However, there is insufficient contemporary clinical data regarding the safety of hypothermia in the human preterm neonate [80]. Moreover, although a variety of agents have shown promising pre-clinical neuro-protection for cerebral injury in full-term neonates, many of these agents have not been extensively evaluated for preterm WMI [155].
Taken together, these studies suggest multiple potential strategies to stimulate regeneration and repair of WMI to circumvent disrupted myelination in neonates. An important future direction will be to define the evolution of cerebral WMI over months to years to identify the relative contributions of disrupted myelination and axonal dysfunction to functional disabilities in preterm survivors. What is the period over which the glial scar remodels and preOL arrest persists? Such information is of critical importance to define the window of opportunity for interventions to promote repair of WMI. Definition of this therapeutic window may be achieved by more sensitive neuroimaging that reliably discriminates disrupted myelination from other pathological processes such as reactive gliosis or disruption of the extracellular matrix that progresses in tandem in the chronic injury environment.
As recently reviewed [20], it is evident from studies of human WMI that preterm infants sustain a unique pattern of injury responses that differ substantially from that seen in rodent models. Some rodent models of hypoxia–ischemia, hyperoxia, or chronic severe hypoxemia generate markedly different patterns of WMI from human. In some instances, these models do not trigger preOL degeneration or reactive gliosis. Diffuse human WMI is also not associated with significant injury to cortical and subcortical gray matter structures, in contrast to some hypoxia–ischemia models in neonatal rodents [117, 122, 177] or fetal rabbits [34] where widespread necrotic and apoptotic neuronal degeneration occurs.
To better define the translational relevance of mechanisms to promote regeneration and repair of WMI, more widespread application of large pre-clinical models is needed. Despite the greater expense and challenges of nonhuman primate or preterm fetal sheep models, they provide access to forms of white matter pathology that more closely approximate that seen in human preterm survivors [10, 78]. Large pre-clinical animal models also provide access to study gyrencephalic white matter, which more closely approximates the human connectome. Recent studies from preterm fetal sheep, for example, support that WMI is accompanied by widespread disturbances in gray matter growth and maturation that resemble those defined in human by volumetric MRI studies [45, 125]. Such findings support that neonatal WMI occurs within the broader scope of global disturbances in cerebral gray matter maturation. It is presently unclear if disturbances in gray matter growth are related to WMI or occur due to independent mechanisms of neuronal dysmaturation. It is also unclear what the relative contributions of WMI and gray matter dysmaturation are to the complex neurobehavioral disabilities sustained by many preterm survivors. It nevertheless seems likely that disturbances in early myelination will have wide-ranging deleterious consequences for the establishment of neuronal connectivity during a critical window in brain development. Hence, developing optimal therapeutic strategies to lessen the impact of WMI may have significant impact on both preterm white and gray matter functional development.
References
(CDC) CfDCaP (2004) Economic costs associated with mental retardation, cerebral palsy, hearing loss and vision impairment–United States, 2003. MMWR Morb Mortal Wkly Rep 53:57–59
Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J (2009) Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 124:717–728. doi:10.1542/peds.2008-2816
Aguirre A, Dupree JL, Mangin JM, Gallo V (2007) A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci 10:990–1002. doi:10.1038/nn1938
Alix JJ, Fern R (2009) Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann Neurol 66:682–693. doi:10.1002/ana.21767
Alix JJ, Zammit C, Riddle A, Meshul CK, Back SA, Valentino M, Fern R (2012) Central axons preparing to myelinate are highly sensitivity to ischemic injury. Ann Neurol 72:936–951. doi:10.1002/ana.23690
Altman DI, Powers WJ, Perlman JM, Herscovitch P, Volpe SL, Volpe JJ (1988) Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults. Ann Neurol 24:218–226
Anderson PJ, De Luca CR, Hutchinson E, Spencer-Smith MM, Roberts G, Doyle LW (2011) Attention problems in a representative sample of extremely preterm/extremely low birth weight children. Dev Neuropsychol 36:57–73. doi:10.1080/87565641.2011.540538
Anderson PJ, Doyle LW (2008) Cognitive and educational deficits in children born extremely preterm. Semin Perinatol 32:51–58. doi:10.1053/j.semperi.2007.12.009
Asher R, Perides G, Vanderhaeghen J, Bignami A (1991) Extracellular matrix of central nervous system white matter: demonstration of an hyaluronan-protein complex. J Neurosci Res 28:410–421
Back S, Riddle A, Hohimer A (2012) The instrumented fetal sheep as a model of cerebral white matter injury in the preterm infant. Neurotherapeutics 9:359–370
Back S, Tuohy T, Chen H, Wallingford N, Craig A, Struve J, Luo N, Banine F, Liu Y, Chang A et al (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 9:966–972
Back SA, Craig A, Kayton R, Luo NL, Meshul C, Allcock N, Fern R (2007) Hypoxia-Ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 27:334–347
Back SA, Gan X-D, Li Y, Rosenberg PA, Volpe JJ (1998) Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241–6253
Back SA, Han BH, Luo NL, Chrichton CA, Tam J, Xanthoudakis S, Arvin KL, Holtzman DM (2002) Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22:455–463
Back SA, Kroenke CD, Sherman LS, Lawrence G, Gong X, Taber EN, Sonnen JA, Larson EB, Montine TJ (2011) White matter lesions defined by diffusion tensor imaging in older adults. Ann Neurol 70:465–476. doi:10.1002/ana.22484
Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21:1302–1312
Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC (2002) Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 61:197–211
Back SA, Luo NL, Mallinson RA, O’Malley JP, Wallen LD, Frei B, Morrow JD, Petito CK, Roberts CT Jr, Murdoch GH et al (2005) Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol 58:108–120
Back SA, Miller SP (2014) Brain injury in premature neonates: a primary cerebral dysmaturation disorder? Ann Neurol 75:469–486. doi:10.1002/ana.24132
Back SA, Rosenberg PA (2014) Pathophysiology of glia in perinatal white matter injury. Glia 62:1790–1815. doi:10.1002/glia.22658
Baltan S, Murphy SP, Danilov CA, Bachleda A, Morrison RS (2011) Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity. J Neurosci 31:3990–3999. doi:10.1523/jneurosci.5379-10.2011
Banker B, Larroche J (1962) Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 7:386–410
Barres B, Schmid R, Sendnte M, Raff M (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283–295
Barrett RD, Bennet L, Naylor A, George SA, Dean JM, Gunn AJ (2012) Effect of cerebral hypothermia and asphyxia on the subventricular zone and white matter tracts in preterm fetal sheep. Brain Res 1469:35–42. doi:10.1016/j.brainres.2012.06.018
Baud O, Greene A, Li J, Wang H, Volpe JJ, Rosenberg PA (2004) Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci 24:1531–1540
Baud O, Haynes R, Wang H, Folkerth RD, Li J, Volpe J, Rosenberg PA (2004) Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci 19:2669–2681
Bax M, Tydeman C, Flodmark O (2006) Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA 296:1602–1608
Beaino G, Khoshnood B, Kaminski M, Pierrat V, Marret S, Matis J, Ledesert B, Thiriez G, Fresson J, Roze JC et al (2010) Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 52:e119–e125. doi:10.1111/j.1469-8749.2010.03612.x
Billiards S, Haynes R, Folkerth R, Borenstein NS, Trachtenberg F, Rowitch D, Ligon K, Volpe J, Kinney H (2008) Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 18:153–163
Billiards SS, Haynes RL, Folkerth RD, Trachtenberg FL, Liu LG, Volpe JJ, Kinney HC (2006) Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 497:199–208. doi:10.1002/cne.20991
Boardman JP, Counsell SJ, Rueckert D, Hajnal JV, Bhatia KK, Srinivasan L, Kapellou O, Aljabar P, Dyet LE, Rutherford MA et al (2007) Early growth in brain volume is preserved in the majority of preterm infants. Ann Neurol 62:185–192. doi:10.1002/ana.21171
Brummelte S, Grunau RE, Chau V, Poskitt KJ, Brant R, Vinall J, Gover A, Synnes AR, Miller SP (2012) Procedural pain and brain development in premature newborns. Ann Neurol 71:385–396. doi:10.1002/ana.22267
Buser J, Maire J, Riddle A, Gong X, Nguyen T, Nelson K, Luo N, Ren J, Struve J, Sherman L et al (2012) Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 71:93–109
Buser J, Segovia K, Dean J, Nelson K, Beardsley D, Gong X, Luo N, Ren J, Wan Y, Riddle A et al (2010) Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia. J Cereb Blood Flow Metab 30:1053–1065
Cao Y, Gunn A, Bennet L, Wu D, George S, Gluckman PD, Shao X-M, Guan J (2003) Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J Cereb Blood Flow Metab 23:739–747
card: MoDPBr (2016) http://www.multivu.com/players/English/7945951-march-of-dimes-premature-birth-report/docs/premature-report-149208847.pdf
Cargill R, Kohama SG, Struve J, Su W, Banine F, Witkowski E, Back SA, Sherman LS (2012) Astrocytes in aged nonhuman primate brain gray matter synthesize excess hyaluronan. Neurobiol Aging 33(830):e813–e824. doi:10.1016/j.neurobiolaging.2011.07.006
Castillo-Melendez M, Chow J, Walker D (2004) Lipid peroxidation, caspase-3 immunoreactivity, and pyknosis in late-gestation fetal sheep brain after umbilical cord occlusion. Pediatr Res 55:864–871
Chau V, Synnes A, Grunau R, Poskitt K, Brant R, Miller S (2013) Abnormal brain maturation in preterm neonates associated with adverse developmental outcomes. Neurology 81:2082–20889
Cheng Y, Deshmukh M, D’Costa A, Demaro J, Gidday J, Shah A, Sun Y, Jacquin M, Johnson E Jr, Holtzman D (1998) Caspase inhibitor affords neuroprotection with delayed adminstration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Investig 101:1992–1999
Clouchoux C, du Plessis AJ, Bouyssi-Kobar M, Tworetzky W, McElhinney DB, Brown DW, Gholipour A, Kudelski D, Warfield SK, McCarter RJ et al (2013) Delayed cortical development in fetuses with complex congenital heart disease. Cereb Cortex 23:2932–2943. doi:10.1093/cercor/bhs281
Constantinou JC, Adamson-Macedo EN, Mirmiran M, Fleisher BE (2007) Movement, imaging and neurobehavioral assessment as predictors of cerebral palsy in preterm infants. J Perinatol 27:225–229. doi:10.1038/sj.jp.7211664
Counsell S, Allsop J, Harrison M, Larkman D, Kennea N, Kapellou O, Cowan F, Hajnal J, Edwards A, Rutherford M (2003) Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics 112:176–180
Craig A, Luo NL, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA (2003) Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231–240
Dean J, McClendon E, Hansen K, Azimi-Zonooz A, Chen K, Riddle A, Gong X, Sharifnia E, Hagen M, Ahmad T et al (2013) Prenatal cerebral ischemia disrupts MRI-defined cortical microstructure through disturbances in neuronal arborization. Sci Transl Med 5:101–111
Dean J, Moravec M, Grafe M, Abend N, Ren J, Gong X, Volpe J, Jensen F, Hohimer A, Back S (2011) Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human. Dev Neurosci 33(3–4):251–260
Deguchi K, Oguchi K, Takashima S (1997) Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol 16:296–300
Delobel-Ayoub M, Arnaud C, White-Koning M, Casper C, Pierrat V, Garel M, Burguet A, Roze JC, Matis J, Picaud JC et al (2009) Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE study. Pediatrics 123:1485–1492. doi:10.1542/peds.2008-1216
Derrick M, Luo NL, Bregman JC, Jilling T, Ji X, Fisher K, Gladson CL, Beardsley DJ, Murdoch GA, Back SA et al (2004) Preterm fetal hypoxia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy? J Neurosci 24:24–34
Dewald LE, Rodriguez JP, Levine JM (2011) The RE1 binding protein REST regulates oligodendrocyte differentiation. J Neurosci 31:3470–3483. doi:10.1523/jneurosci.2768-10.2011
Dimitropoulos A, McQuillen PS, Sethi V, Moosa A, Chau V, Xu D, Brant R, Azakie A, Campbell A, Barkovich AJ et al (2013) Brain injury and development in newborns with critical congenital heart disease. Neurology 81:241–248. doi:10.1212/WNL.0b013e31829bfdcf
Doyle L (2012) Antenatal magnesium sulfate and neuroprotection. Curr Opin Pediatr 24:154–159
Drobyshevsky A, Derrick M, Prasad P, Ji X, Englof I, Tan S (2007) Fetal brain magnetic resonance imaging response acutely to hypoxia-ischemia predicts postnatal outcome. Ann Neurol 61:307–314
Drobyshevsky A, Derrick M, Wyrwicz A, Ji X, Englof I, Ullman L, Zelaya M, Northington F, Tan S (2007) White matter injury correlates with hypertonia in an animal model of cerebral palsy. J Cereb Blood Flow Metab 27:270–281
Drobyshevsky A, Luo K, Derrick M, Yu L, Du H, Prasad PV, Vasquez-Vivar J, Batinic-Haberle I, Tan S (2012) Motor deficits are triggered by reperfusion-reoxygenation injury as diagnosed by MRI and by a mechanism involving oxidants. J Neurosci 32:5500–5509. doi:10.1523/jneurosci.5986-11.2012
Drobyshevsky A, Song S-K, Gamkrelidze G, Wyrwicz A, Derrick M, Meng F, Li L, Ji X, Trommer D, Beardsley D et al (2005) Developmental changes in diffusion anisotropy coincide with immature oligodendrocyte progression and maturation of compound action potential. J Neurosci 25:5988–5997
Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA (2010) Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597–611. doi:10.1016/j.neuron.2010.01.027
Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA (2009) Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172–185. doi:10.1016/j.cell.2009.04.031
Engelhardt E, Inder TE, Alexopoulos D, Dierker DL, Hill J, Van Essen D, Neil JJ (2015) Regional impairments of cortical folding in premature infants. Ann Neurol 77:154–162. doi:10.1002/ana.24313
Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571–1585. doi:10.1101/gad.1806309
Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R et al (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009–1016. doi:10.1038/nn.2855
Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ (2010) Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 225:18–23. doi:10.1016/j.expneurol.2009.12.020
Fauchere JC, Koller BM, Tschopp A, Dame C, Ruegger C, Bucher HU (2015) Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr. doi:10.1016/j.jpeds.2015.02.052
Feigenson K, Reid M, See J, Crenshaw EB 3rd, Grinspan JB (2009) Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42:255–265. doi:10.1016/j.mcn.2009.07.010
Felling RJ, Snyder MJ, Romanko MJ, Rothstein RP, Ziegler AN, Yang Z, Givogri MI, Bongarzone ER, Levison SW (2006) Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci 26:4359–4369. doi:10.1523/jneurosci.1898-05.2006
Fern R, Davis P, Waxman S, Ransom B (1998) Axon conduction and survival in CNS white matter during energy deprivation: a developmental study. J Neurophysiol 79:95–105
Fern R, Moller T (2000) Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20:34–42
Ferriero DM, Miller SP (2010) Imaging selective vulnerability in the developing nervous system. J Anat 217:429–435. doi:10.1111/j.1469-7580.2010.01226.x
Folkerth R, Haynes R, Borenstein NS, Volpe JJ, Kinney HC (2004) Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol 63:990–999
Fragoso G, Martinez-Bermudez A, Lui H-N, Khorchid A, Chemtob S, Mushynski W, Almazan G (2004) Developmental differences in H2O2-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3. J Neurochem 90:392–404
French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB (2009) Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 87:3076–3087. doi:10.1002/jnr.22139
Gaynor J (2004) Periventricular leukomalacia following neonatal and infant cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 7:133–140
Glass HC, Fujimoto S, Ceppi-Cozzio C, Bartha AI, Vigneron DB, Barkovich AJ, Glidden DV, Ferriero DM, Miller SP (2008) White-matter injury is associated with impaired gaze in premature infants. Pediatr Neurol 38:10–15. doi:10.1016/j.pediatrneurol.2007.08.019
Gleason CA, Hamm C, Jones MD Jr (1989) Cerebral blood flow, oxygenation, and carbohydrate metabolism in immature fetal sheep in utero. AmJPhysiol 256:R1264–R1268
Gonzalez FF, Larpthaveesarp A, McQuillen P, Derugin N, Wendland M, Spadafora R, Ferriero DM (2013) Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke 44:753–758. doi:10.1161/strokeaha.111.000104
Greisen G (1986) Cerebral blood flow in preterm infants during the first week of life. Acta Paediatr Scand 75:43–51
Gressens P, Schwendimann L, Husson I, Sarkozy G, Mocaer E, Vamecq J, Spedding M (2008) Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur J Pharmacol 588:58–63. doi:10.1016/j.ejphar.2008.04.016
Griffith JL, Shimony JS, Cousins SA, Rees SE, McCurnin DC, Inder TE, Neil JJ (2012) MR imaging correlates of white-matter pathology in a preterm baboon model. Pediatr Res 71:185–191. doi:10.1038/pr.2011.33
Groenendaal F, Termote JU, van der Heide-Jalving M, van Haastert IC, de Vries LS (2010) Complications affecting preterm neonates from 1991 to 2006: what have we gained? Acta Paediatr 99:354–358. doi:10.1111/j.1651-2227.2009.01648.x
Gunn A, Bennet L (2008) Brain cooling for preterm infants. Clin Perinatal 35:735–748
Hack M, Taylor H, Drotar D, Schluchter M, Cartar L, Andreias L, Wilson-Costello D, Klein N (2005) Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990’s. JAMA 294:318–325
Hagberg H, Peebles D, Mallard C (2002) Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. MRDD Res Rev 8:30–38
Hagen MW, Riddle A, McClendon E, Gong X, Shaver D, Srivastava T, Dean JM, Bai JZ, Fowke TM, Gunn AJ et al (2014) Role of recurrent hypoxia-ischemia in preterm white matter injury severity. PLoS ONE 9:e112800. doi:10.1371/journal.pone.0112800
Hamrick S, Miller SP, Leonard C, Glidden D, Goldstein R, Ramaswamy V, Piecuchi R, Ferriero DM (2004) Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia. J Pediatr 145:593–599
Han B, D’Costa A, Back SA, Parsadian M, Patel S, Shah A, Gidday J, Srinvasan A, Deshmukh M, Holtzman D (2000) BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 7:38–53
Hasegawa K, Yoshioka H, Sawada T, Nishikawa H (1991) Lipid peroxidation in neonatal mouse brain subjected to two different types of hypoxia. Brain Dev 13:101–103
Haynes RL, Billiards SS, Borenstein NS, Volpe JJ, Kinney HC (2008) Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 63:656–661. doi:10.1203/PDR.0b013e31816c825c
Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62:441–450
Hirayama A, Okoshi Y, Hachiya Y, Ozawa Y, Ito M, Kida Y, Imai Y, Kohsaka S, Takashima S (2001) Early immunohistochemical detection of axonal damage and glial activation in extremely immature brains with periventricular leukomalacia. Clin Neuropathol 20:87–91
Huppi PS, Murphy B, Maier SE, Zientara GP, Inder TE, Barnes PD, Kikinis R, Jolesz FA, Volpe JJ (2001) Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 107:455–460
Iida K, Takashima S, Ueda K (1995) Immunohistochemical study of myelination and oligodendrocyte in infants with periventricular leukomalacia. Pediatr Neurol 13:296–304
Inage YW, Itoh M, Takashima S (2000) Correlation between cerebrovascular maturity and periventricular leukomalacia. Pediatr Neurol 22:204–208
Inder TE, Anderson NJ, Spencer C, Wells S, Volpe JJ (2003) White matter injury in the premature infant: a comparison between serial cranial sonographic and MR findings at term. AJNR AmJNeuroradiol 24:805–809
Ivkovic S, Canoll P, Goldman JE (2008) Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci 28:914–922. doi:10.1523/jneurosci.4327-07.2008
Iwai M, Stetler RA, Xing J, Hu X, Gao Y, Zhang W, Chen J, Cao G (2010) Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke 41:1032–1037. doi:10.1161/strokeaha.109.570325
Jacobson LK, Dutton GN (2000) Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol 45:1–13
Jakovcevski I, Filipovic R, Mo Z, Rakic S, Zecevic N (2009) Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat 3:5. doi:10.3389/neuro.05.005.2009
Jakovcevski I, Zecevic N (2005) Sequence of oligodendrocyte development in the human fetal telencephalon. Glia 49:480–491
Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515–540
Jantzie LL, Miller RH, Robinson S (2013) Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury. Pediatr Res 74:658–667. doi:10.1038/pr.2013.155
John G, Shankar S, Shafit-Zagardo B, Massimi A, Lee S, Raine C, Brosnan C (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115–1121
Juul SE, Mayock DE, Comstock BA, Heagerty PJ (2015) Neuroprotective potential of erythropoietin in neonates; design of a randomized trial. Maternal Health Neonatol Perinatol 1:27. doi:10.1186/s40748-015-0028-z
Kako E, Kaneko N, Aoyama M, Hida H, Takebayashi H, Ikenaka K, Asai K, Togari H, Sobue K, Sawamoto K (2012) Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative. Stem cells 30:2234–2247. doi:10.1002/stem.1202
Kersbergen KJ, Benders MJ, Groenendaal F, Koopman-Esseboom C, Nievelstein RA, van Haastert IC, de Vries LS (2014) Different patterns of punctate white matter lesions in serially scanned preterm infants. PLoS ONE 9:e108904. doi:10.1371/journal.pone.0108904
Kesler SR, Reiss AL, Vohr B, Watson C, Schneider KC, Katz KH, Maller-Kesselman J, Silbereis J, Constable RT, Makuch RW et al (2008) Brain volume reductions within multiple cognitive systems in male preterm children at age twelve. J Pediatr. doi:10.1016/j.jpeds.2007.08.009
Lasry O, Shevell MI, Dagenais L (2010) Cross-sectional comparison of periventricular leukomalacia in preterm and term children. Neurology 74:1386–1391. doi:10.1212/WNL.0b013e3181dad62d
Lee Y, Morrison B, Li Y, Lengacher S, Farah M, Hoffman P, Liu Y, Tsinalia A, Jin L, Zhang P-W et al (2012) Oligodendrolia metabolically support axons and contribute to neurodegeneration. Nature 487:443–448
Li AM, Chau V, Poskitt KJ, Sargent MA, Lupton BA, Hill A, Roland E, Miller SP (2009) White matter injury in term newborns with neonatal encephalopathy. Pediatr Res 65:85–89. doi:10.1203/PDR.0b013e31818912d2
Li W, Zhang B, Tang J, Cao Q, Wu Y, Wu C, Guo J, Ling EA, Liang F (2007) Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J Neurosci 27:2606–2616. doi:10.1523/jneurosci.4181-06.2007
Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A (2009) Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg 137:529–536. doi:10.1016/j.jtcvs.2008.10.025 (discussion 536-527)
Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL Jr, Guizard N, McGrath E, Geva J, Annese D et al (2010) Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 121:26–33. doi:10.1161/circulationaha.109.865568
Lin S, Rhodes P, Lei M, Zhang F, Cai Z (2004) a-Phenyl-n-tert-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain. Brain Res 1007:132–141
Litt J, Taylor H, Klein N, Hack M (2005) Learning disabilities in children with very low birthweight:prevalence, neuropsychological correlates and educational interventions. J Learn Disabil 8:130–141
Liu J, Li J, Qin GL, Chen YH, Wang Q (2008) Periventricular leukomalacia in premature infants in mainland China. Am J Perinatol 25:535–540. doi:10.1055/s-0028-1083841
Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE (2017) Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388:3027–3035. doi:10.1016/s0140-6736(16)31593-8
Liu W, Shen Y, Plane JM, Pleasure DE, Deng W (2011) Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp Neurol 230:227–239. doi:10.1016/j.expneurol.2011.04.021
Lodygensky GA, West T, Moravec MD, Back SA, Dikranian K, Holtzman DM, Neil JJ (2011) Diffusion characteristics associated with neuronal injury and glial activation following hypoxia-ischemia in the immature brain. Magn Reson Med 66:839–845. doi:10.1002/mrm.22869
Loeliger M, Inder T, Cain S, Ramesh RC, Camm E, Thomson MA, Coalson J, Rees SM (2006) Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics 118:1640–1653. doi:10.1542/peds.2006-0653
Maalouf E, Duggan P, Counsell SJ, Rutherford MA, Cowan FM, Azzopardi D, Edwards A (2001) Comparison of findings on cranial ultrasound and magnetic resonance imaging in preterm infants. Pediatrics 107:719–727
Mallard E, Rees S, Stringer M, Cock M, Harding R (1998) Effects of chronic placental insufficiency on brain development in fetal sheep. Pediatr Res 43:262–270
Marin-Padilla M (1997) Developmental neuropathology and impact of perinatal brain damage. II: white matter lesions of the neocortex. J Neuropathol Exp Neurol 56:219–235
Marret S, Mukendi R, Gadisseux J-F, Gressens P, Evrard P (1995) Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 54:358–370
Martinez-Biarge M, Madero R, Gonzalez A, Quero J, Garcia-Alix A (2012) Perinatal morbidity and risk of hypoxic-ischemic encephalopathy associated with intrapartum sentinel events. Am J Obstet Gynecol. doi:10.1016/j.ajog.2011.09.031
McClain CR, Sim FJ, Goldman SA (2012) Pleiotrophin suppression of receptor protein tyrosine phosphatase-beta/zeta maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J Neurosci 32:15066–15075. doi:10.1523/jneurosci.1320-12.2012
McClendon E, Chen K, Gong X, Sharifnia E, Hagen M, Cai V, Shaver DC, Riddle A, Dean JM, Gunn AJ et al (2014) Prenatal cerebral ischemia triggers dysmaturation of caudate projection neurons. Ann Neurol. doi:10.1002/ana.24100
McClure M, Riddle A, Manese M, Luo N, Rorvik D, Kelly K, Barlow C, Kelly JJEJ, Bernard SL, Glenny RW, Barlow CH, Vinecore K, Roberts C et al (2008) Cerebral blood flow heterogeneity in preterm sheep: lack of physiological support for vascular boundary zones in fetal cerebral white matter. J Cereb Blood Flow Metab 28:995–1008
McQuillen P, Miller S (2010) Congenital heart disease and brain development. Ann N Y Acad Sci 1184:68–86
Ment LR, Hirtz D, Huppi PS (2009) Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol 8:1042–1055. doi:10.1016/s1474-4422(09)70257-1
Mercier CE, Dunn MS, Ferrelli KR, Howard DB, Soll RF (2010) Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003. Neonatology 97:329–338. doi:10.1159/000260136
Miller S, Vigneron D, Henry R, Bohland M, Ceppi-Cozzio C, Hoffman C, Newton N, Partridge JC, Ferriero DM, Barkovich AJ (2002) Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn ResonImaging 16:621–632
Miller SP, Cozzio CC, Goldstein RB, Ferriero DM, Partridge JC, Vigneron DB, Barkovich AJ (2003) Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonagraphy findings. AJNR Am J Neuroradiol 24:1661–1669
Miller SP, Ferriero DM, Leonard C, Piecuch R, Glidden D, Partridge JC, Perez M, Mukherjee P, Vigneron D, Barkovich AJ (2005) Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse neurodevelopmental outcome. J Pediatr 147:609–616
Miller SP, McQuillen PS, Hamrick S, Xu D, Glidden DV, Charlton N, Karl T, Azakie A, Ferriero DM, Barkovich AJ et al (2007) Abnormal brain development in newborns with congenital heart disease. N Engl J Med 357:1928–1938. doi:10.1056/NEJMoa067393
Mishra OP, Delivoria-Papadopoulos M (1989) Lipid peroxidation in developing fetal guinea pig brain during normoxia and hypoxia. Brain Res Dev Brain Res 45:129–135
Miyawaki T, Matsui K, Takashima S (1998) Developmental characteristics of vessel density in the human fetal and infant brains. Early Hum Dev 53:65–72
Montine K, Quinn J, Zhang J, Fessel J, Roberts LJ, Morrow JD, Montine TJ (2004) Isoprostanes and related products of lipid peroxidation. Chem Phy Lipids 128:117–124
Natalucci G, Latal B, Koller B, Ruegger C, Sick B, Held L, Bucher HU, Fauchere JC (2016) Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: a randomized clinical trial. JAMA 315:2079–2085. doi:10.1001/jama.2016.5504
Nelson MD Jr, Gonzalez-Gomez I, Gilles FH (1991) Dyke Award. The search for human telencephalic ventriculofugal arteries. AJNR AmJNeuroradiol 12:215–222
Ness JK, Romanko MJ, Rothstein RP, Wood TL, Levison SW (2001) Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 23:203–208
O’Gorman RL, Bucher HU, Held U, Koller BM, Huppi PS, Hagmann CF (2015) Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants. Brain 138:388–397. doi:10.1093/brain/awu363
Pagliano E, Fedrizzi E, Erbetta A, Bulgheroni S, Solari A, Bono R, Fazzi E, Andreucci E, Riva D (2007) Cognitive profiles and visuoperceptual abilities in preterm and term spastic diplegic children with periventricular leukomalacia. J Child Neurol 22:282–288. doi:10.1177/0883073807300529
Peterson BS, Vohr B, Staib LH, Cannistraci CJ, Dolberg A, Schneider KC, Katz KH, Westerveld M, Sparrow S, Anderson AW et al (2000) Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 284:1939–1947
Pierson CR, Folkerth RD, Billiards SS, Trachtenberg FL, Drinkwater ME, Volpe JJ, Kinney HC (2007) Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol 114:619–631. doi:10.1007/s00401-007-0295-5
Powers WJ, Grubb RL, Darriet D, Raichle ME (1985) Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 5:600–608
Preston M, Gong X, Su W, Matsumoto SG, Banine F, Winkler C, Foster S, Xing R, Struve J, Dean J et al (2013) Digestion products of the PH20 hyaluronidase inhibit remyelination. Ann Neurol 73:266–280. doi:10.1002/ana.23788
Pryds O, Andersen GE, Friis-Hansen B (1990) Cerebral blood flow reactivity in spontaneously breathing, preterm infants shortly after birth. Acta Paediatr Scand 79:391–396
Pryds O, Greisen G, Friis-Hansen B (1988) Compensatory increase of CBF in preterm infants during hypoglycaemia. Acta Paediatr Scand 77:632–637
Pryds O, Greisen G, Friis-Hansen B (1989) Heterogeneity of cerebral vasoreactivity in preterm infants supported by machanical ventilation. J Pediatr 115:638–645
Rakic S, Zecevic N (2003) Early oligodendrocyte precursor cells in the human fetal telencephalon. Glia 41:117–127
Rees S, Mallard C, Breen S, Stringer M, Cock M, Harding R (1998) Fetal brain injury following prolonged hypoxemia and placental insufficiency: a review. Comp Biochem Physiol A 119:653–660
Riddle A, Dean J, Buser J, Gong X, Maire J, Chen K, Ahmad T, Chen V, Nguyen T, Kroenke C et al (2011) Histopathological correlates of MRI-defined chronic perinatal white matter injury. Ann Neurol 70:493–507
Riddle A, Luo N, Manese M, Beardsley D, Green L, Rorvik D, Kelly K, Barlow C, Kelly J, Hohimer A et al (2006) Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J Neurosci 26:3045–3055
Riddle A, Maire J, Cai V, Nguyen T, Gong X, Hansen K, Grafe MR, Hohimer AR, Back SA (2013) Hemodynamic and metabolic correlates of perinatal white matter injury severity. PLoS ONE 8:e82940. doi:10.1371/journal.pone.0082940
Riddle A, Maire J, Gong X, Chen KX, Kroenke CD, Hohimer AR, Back SA (2012) Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injury. Stroke 43:178–184. doi:10.1161/STROKEAHA.111.632265
Robertson NJ, Tan S, Groenendaal F, van Bel F, Juul SE, Bennet L, Derrick M, Back SA, Valdez RC, Northington F et al (2012) Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr 160(544–552):e544. doi:10.1016/j.jpeds.2011.12.052
Rosenberg PA, Weimin D, Gan XD, Ali S, Back SA, Sanchez RM, Segal MM, Follet PE, Jensen FE, Volpe JJ (2003) Mature myelin basic protein expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 71:237–245
Scafidi J, Fagel DM, Ment LR, Vaccarino FM (2009) Modeling premature brain injury and recovery. Int J Dev Neurosci 27:863–871. doi:10.1016/j.ijdevneu.2009.05.009
Scafidi J, Hammond TR, Scafidi S, Ritter J, Jablonska B, Roncal M, Szigeti-Buck K, Coman D, Huang Y, McCarter RJ Jr et al (2014) Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature 506:230–234. doi:10.1038/nature12880
Segovia K, McClure M, Moravec M, Luo N, Wang Y, Gong X, Riddle A, Craig A, Struve J, Sherman L et al (2008) Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 63:517–526
Shen S, Li J, Casaccia-Bonnefil P (2005) Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 169:577–589. doi:10.1083/jcb.200412101
Shin D, Shin JY, McManus MT, Ptacek LJ, Fu YH (2009) Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 66:843–857. doi:10.1002/ana.21927
Silbereis J, Huang E, Back S, Rowitch D (2010) Toward improved animal models of neonatal white matter injury associate with cerebral palsy. Dis Models Mech 3:678–688
Sizonenko SV, Bednarek N, Gressens P (2007) Growth factors and plasticity. Semin Fetal Neonatal Med 12:241–249. doi:10.1016/j.siny.2007.01.007
Skranes J, Lohaugen GC, Martinussen M, Haberg A, Brubakk AM, Dale AM (2013) Cortical surface area and IQ in very-low-birth-weight (VLBW) young adults. Cortex 49:2264–2271. doi:10.1016/j.cortex.2013.06.001
Sloane J, Batt C, Ma Y, Harris Z, Trapp B, Vartanian T (2010) Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci USA 107:11555–11560
Smith GC, Gutovich J, Smyser C, Pineda R, Newnham C, Tjoeng TH, Vavasseur C, Wallendorf M, Neil J, Inder T (2011) Neonatal intensive care unit stress is associated with brain development in preterm infants. Ann Neurol 70:541–549. doi:10.1002/ana.22545
Soria-Pastor S, Gimenez M, Narberhaus A, Falcon C, Botet F, Bargallo N, Mercader JM, Junque C (2008) Patterns of cerebral white matter damage and cognitive impairment in adolescents born very preterm. Int J Dev Neurosci 26:647–654. doi:10.1016/j.ijdevneu.2008.08.001
Soria-Pastor S, Padilla N, Zubiaurre-Elorza L, Ibarretxe-Bilbao N, Botet F, Costas-Moragas C, Falcon C, Bargallo N, Mercader JM, Junque C (2009) Decreased regional brain volume and cognitive impairment in preterm children at low risk. Pediatrics 124:e1161–e1170. doi:10.1542/peds.2009-0244
Soul J, Hammer P, Tsuji M, Saul J, Bassan H, Limperopoulous C, Disalvo D, Moore M, Akins P, Ringer S et al (2007) Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res 61:467–473
Spittle AJ, Boyd RN, Inder TE, Doyle LW (2009) Predicting motor development in very preterm infants at 12 months’ corrected age: the role of qualitative magnetic resonance imaging and general movements assessments. Pediatrics 123:512–517. doi:10.1542/peds.2008-0590
Spittle AJ, Brown NC, Doyle LW, Boyd RN, Hunt RW, Bear M, Inder TE (2008) Quality of general movements is related to white matter pathology in very preterm infants. Pediatrics 121:e1184–e1189. doi:10.1542/peds.2007-1924
Sun L, Macgowan CK, Sled JG, Yoo SJ, Manlhiot C, Porayette P, Grosse-Wortmann L, Jaeggi E, McCrindle BW, Kingdom J et al (2015) Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation 131:1313–1323. doi:10.1161/circulationaha.114.013051
Szymonowicz W, Walker AM, Cussen L, Cannata J, Yu VY (1988) Developmental changes in regional cerebral blood flow in fetal and newborn lambs. AmJPhysiol 254:H52–H58
Takashima S, Tanaka K (1978) Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol 35:11–16
Tawk M, Makoukji J, Belle M, Fonte C, Trousson A, Hawkins T, Li H, Ghandour S, Schumacher M, Massaad C (2011) Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 31:3729–3742. doi:10.1523/jneurosci.4270-10.2011
Tsuji M, Saul J, du Plessis A, Eichenwald E, Sobh J, Crocker R, Volpe J (2000) Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants. Pediatrics 106:625–632
Vannucci RC, Vannucci SJ (2005) Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci 27:81–86. doi:10.1159/000085978
Verney C, Pogledic I, Biran V, Adle-Biassette H, Fallet-Bianco C, Gressens P (2012) Microglial reaction in axonal crossroads is a hallmark of noncystic periventricular white matter injury in very preterm infants. J Neuropathol Exp Neurol 71:251–264. doi:10.1097/NEN.0b013e3182496429
Vinall J, Miller SP, Chau V, Brummelte S, Synnes AR, Grunau RE (2012) Neonatal pain in relation to postnatal growth in infants born very preterm. Pain 153:1374–1381. doi:10.1016/j.pain.2012.02.007
Vohr BR (2014) Neurodevelopmental outcomes of extremely preterm infants. Clin Perinatol 41:241–255. doi:10.1016/j.clp.2013.09.003
Volpe JJ (2009) Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 8:110–124
Vose LR, Vinukonda G, Jo S, Miry O, Diamond D, Korumilli R, Arshad A, Zia MT, Hu F, Kayton RJ et al (2013) Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage. J Neurosci 33:17232–17246. doi:10.1523/jneurosci.2713-13.2013
Wang Y, Cheng X, He Q, Zheng Y, Kim D, Whittemore S, Cao Q (2011) Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 31:6053–6058
Wilson-Costello D, Fridedman H, Minich N, Fanaroff A, Hack M (2005) Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 115:997–1003
Wright J, Zhang G, Yu T-S, Kernie S (2010) Age-related changes in the oligodendrocyte progenitor pool influence brain remodeling after injury. Dev Neurosci 32:499–509
Wu YW, Mathur AM, Chang T, McKinstry RC, Mulkey SB, Mayock DE, Van Meurs KP, Rogers EE, Gonzalez FF, Comstock BA et al (2016) High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial. Pediatrics. doi:10.1542/peds.2016-0191
Yamada M, Burke C, Colditz P, Johnson DW, Gobe GC (2011) Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain. J Pathol 224:101–109. doi:10.1002/path.2862
Yang Z, Levison S (2006) Hypoxia/ischemia expands the regenerative capacity of progenitors in the perinatal subventricular zone. Neuroscience 139:555–564
Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H et al (2009) HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12:829–838. doi:10.1038/nn.2333
Zaidi A, Bessert D, Ong J, Xu H, Barks J, Silverstein F (2004) New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. Glia 46:380–390
Zhiheng H, Liu J, Cheung P-Y, Chen C (2009) Long-term cognitive impairment and myelination deficiency in a rat model of perinatal hypoxic-ischemia brain injury. Brain Res 1301:100–109
Zhu MY, Milligan N, Keating S, Windrim R, Keunen J, Thakur V, Ohman A, Portnoy S, Sled JG, Kelly E et al (2016) The hemodynamics of late-onset intrauterine growth restriction by MRI. Am J Obstet Gynecol. doi:10.1016/j.ajog.2015.10.004
Acknowledgements
Dr. Back is supported by the NIH (National Institutes of Neurological Disorders and Stroke: 1RO1NS054044, R37NS045737; National Institute on Aging: 1R01AG031892-01) and the American Heart Association (17GRNT33370058).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Back, S.A. White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol 134, 331–349 (2017). https://doi.org/10.1007/s00401-017-1718-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-017-1718-6